Patient-Focused Drug Development Methods for Benefit-Risk Assessments: A Case Study Using Discrete Choice Experiment for Antiepileptic Drugs

Clinical Pharmacology and Therapeutics- United States

doi 10.1002/cpt.1231

Full Text

Abstract

Available in

Categories

Date

October 25, 2018

Authors

Emily A.F. Holmes

Catrin Plumpton

Paula Williamson

Dyfrig A. Hughes

Publisher

Wiley

Related search

Patient Preferences for Asthma Therapy: A Discrete Choice Experiment

Primary Care Respiratory Journal

English

Using Discrete Choice Experiment to Elicit Patient Preferences for Osteoporosis Drug Treatments: Where to From Here?

Arthritis Research and Therapy

English

Patient and Physician Preferences for Treating Adjuvant Melanoma: A Discrete Choice Experiment

Journal of Cancer Therapy

English

Societal Preferences for Funding Orphan Drugs in the UK: An Application of Value Based Pricing Using Discrete Choice Experiment Methods

Value in Health

Occupational Health

English

A Discrete Choice Experiment Investigating Preferences for Funding Drugs Used to Treat Orphan Diseases: An Exploratory Study

Health Economics, Policy and Law

English

Patient Preferences for Nutritional Supplementation to Improve Fracture Healing: A Discrete Choice Experiment

English

Education and Patient Preferences for Treating Type 2 Diabetes: A Stratified Discrete-Choice Experiment

Patient Preference and Adherence

Social Sciences

English

PSY42 Chronic Pain: Patient Treatment Preferences - A Discrete Choice Experiment

Value in Health

Occupational Health

English

Patient Preferences in Regulatory Benefit-Risk Assessments: A US Perspective

Value in Health

Occupational Health

English